(-)-Semiglabrin



Compound IDCDAMM00170
Common name(-)-Semiglabrin
IUPAC name[(12S,15R,16R)-14,14-dimethyl-6-oxo-4-phenyl-3,11,13-trioxatetracyclo[8.6.0.02,7.012,16]hexadeca-1(10),2(7),4,8-tetraen-15-yl] acetate
Molecular formulaC23H20O6

Experimental data

Retention time52.94
Adduct[M+H]+
Actual mz393.132
Theoretical mz393.133
Error2.03
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.0563

Identifiers and class information

Inchi keyXTIQPKJOGKMOSY-UHFFFAOYNA-N
SmilesCC(=O)OC1C2C(OC3=C2C4=C(C=C3)C(=O)C=C(O4)C5=CC=CC=C5)OC1(C)C
SuperclassPhenylpropanoids and polyketides
ClassFlavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)1
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)0
Molecular weight (mol_MW)392.407
Computed dipole moment(dipole)8.452
Total solvent accessible surface area (SASA)589.489
Hydrophobic component of SASA (FOSA)228.636
Hydrophilic component of SASA (FISA)78.658
Pie component of the SASA (PISA)282.195
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1121.06
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)6
Free energy of solvation of dipole (dip^2/V)0.0637258
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.885337
Predicted polarizability in cubic angstroms (QPpolrz)40.764
Predicted hexadecane/gas partition coefficient (QPlogPC16)11.279
Predicted octanol/gas partition coefficient (QPlogPoct)17.68
Predicted water/gas partition coefficient (QPlogPw)9.282
Predicted octanol/water partition coefficient (QPlogPo/w)3.473
Predicted aqueous solubility (QPlogS)-4.084
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.683
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.733
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)1778.21
Predicted brain/blood partition coefficient (QPlogBB)-0.166
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)921.623
Predicted skin permeability, log Kp (QPlogKp)-1.879
PM3 calculated ionization potential (IP(ev))9.327
PM3 calculated electron affinity (EA(eV))0.86
Number of likely metabolic reactions (#metab)1
Prediction of binding to human serum albumin (QPlogKhsa)0.225
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)82.265
Number of nitrogen and oxygen atoms (#NandO)6
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
Q99720SIGMAR1Sigma opioid receptorT46360SEA
P08183ABCB1P-glycoprotein 1T25258SEA
O95271TNKSTankyrase-1T83059SEA
O14746TERTTelomerase reverse transcriptaseT86052SEA
Q9UNQ0ABCG2ATP-binding cassette sub-family G member 2T56556SEA
Q16678CYP1B1Cytochrome P450 1B1T92521SEA
P16152CBR1Carbonyl reductase [NADPH] 1T70518SEA
Q13332PTPRSReceptor-type tyrosine-protein phosphatase ST10147SEA
Q9Y271CYSLTR1Cysteinyl leukotriene receptor 1T71192SEA
P16220CREB1Cyclic AMP-responsive element-binding proteinT92098SEA
Q96HK3CALMCalmodulinT39610SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T46360DI0105Cough[ICD-11: MD12]Q99720SIGMAR1
T25258DI0238Lung cancer[ICD-11: 2C25]P08183ABCB1
T83059DI0060Brain cancer[ICD-11: 2A00]O95271TNKS
T83059DI0062Breast cancer[ICD-11: 2C60-2C6Y]O95271TNKS
T83059DI0321Ovarian cancer[ICD-11: 2C73]O95271TNKS
T83059DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]O95271TNKS
T86052DI0184Human immunodeficiency virus disease[ICD-11: 1C60-1C62]O14746TERT
T86052DI0284Myelodysplastic syndrome[ICD-11: 2A37]O14746TERT
T86052DI0326Pancreatic cancer[ICD-11: 2C10]O14746TERT
T56556DI0218Irritable bowel syndrome[ICD-11: DD91]Q9UNQ0ABCG2
T56556DI0366Rheumatoid arthritis[ICD-11: FA20]Q9UNQ0ABCG2
T70518DI0037Asthma[ICD-11: CA23]P16152CBR1
T10147DI0057Bone paget disease[ICD-11: FB85]Q13332PTPRS
T71192DI0037Asthma[ICD-11: CA23]Q9Y271CYSLTR1
T39610DI0068Cardiac arrhythmia[ICD-11: BC9Z]Q96HK3CALM
T39610DI0243Malaria[ICD-11: 1F40-1F45]Q96HK3CALM
T39610DI0370Schizophrenia[ICD-11: 6A20]Q96HK3CALM

Copyright © 2025